Abstract
These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in 2012. Since the release of the previous guidelines, the scale-up of antiretroviral therapy (ART) in southern Africa has continued. Cohort studies from the region show excellent clinical outcomes; however, ART is still being initiated late (in advanced disease) in some patients, resulting in relatively high early mortality rates. New data on antiretroviral drugs have become available. Although currently few, there are patients in the region who are failing protease-inhibitor-based second-line regimens. To address this, guidelines on third-line therapy have been expanded.
| Original language | English |
|---|---|
| Pages (from-to) | 121-143 |
| Number of pages | 23 |
| Journal | Southern African Journal of HIV Medicine |
| Volume | 15 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1 Dec 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Adult antiretroviral therapy guidelines 2014'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver